ATE279113T1 - HYPOXANTHINE AND THIOHYPXANTHINE COMPOUNDS - Google Patents
HYPOXANTHINE AND THIOHYPXANTHINE COMPOUNDSInfo
- Publication number
- ATE279113T1 ATE279113T1 AT00953925T AT00953925T ATE279113T1 AT E279113 T1 ATE279113 T1 AT E279113T1 AT 00953925 T AT00953925 T AT 00953925T AT 00953925 T AT00953925 T AT 00953925T AT E279113 T1 ATE279113 T1 AT E279113T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- thiohypxanthine
- hypoxanthine
- inhibitors
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 title 2
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 title 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Disclosed are compounds of formula (I) wherein R3, R6, R8 are as described herein. The compounds are effective selective PDE IV inhibitors.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14862399P | 1999-08-12 | 1999-08-12 | |
PCT/US2000/021836 WO2001011967A1 (en) | 1999-08-12 | 2000-08-09 | Novel hypoxanthine and thiohypoxanthine compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE279113T1 true ATE279113T1 (en) | 2004-10-15 |
Family
ID=22526585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00953925T ATE279113T1 (en) | 1999-08-12 | 2000-08-09 | HYPOXANTHINE AND THIOHYPXANTHINE COMPOUNDS |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1202628B1 (en) |
JP (1) | JP2003506467A (en) |
AT (1) | ATE279113T1 (en) |
AU (1) | AU6629000A (en) |
CA (1) | CA2379356A1 (en) |
DE (1) | DE60014915T2 (en) |
WO (1) | WO2001011967A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003037345A1 (en) * | 2001-10-26 | 2003-05-08 | Sciclone Pharmaceuticals, Inc. | Pharmaceutical formulations comprising substituted xanthine compounds |
AR039385A1 (en) | 2002-04-19 | 2005-02-16 | Astrazeneca Ab | THIOXANTINE DERIVATIVES AS INHIBITORS OF MIELOPEROXIDASA |
CN114588161A (en) * | 2020-12-07 | 2022-06-07 | 四川大学华西医院 | Hypoxlavine derivatives with prevention and treatment of pneumonia |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL24642A (en) * | 1965-11-18 | 1971-06-23 | Rashi M | Method for preparation of 6-thioxo purines from 6-methylthio purines |
GB9312853D0 (en) * | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
DE69531506T2 (en) * | 1994-12-13 | 2004-06-24 | Euroceltique S.A. | ARYLTHIOXANTHINE |
US5864037A (en) * | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
JP2002508378A (en) * | 1997-12-12 | 2002-03-19 | ユーロ−セルティーク,エス.エイ. | Method for producing 3-substituted adenine and imidazopyridine |
-
2000
- 2000-08-09 EP EP00953925A patent/EP1202628B1/en not_active Expired - Lifetime
- 2000-08-09 AT AT00953925T patent/ATE279113T1/en not_active IP Right Cessation
- 2000-08-09 JP JP2001516330A patent/JP2003506467A/en active Pending
- 2000-08-09 CA CA002379356A patent/CA2379356A1/en not_active Abandoned
- 2000-08-09 AU AU66290/00A patent/AU6629000A/en not_active Abandoned
- 2000-08-09 DE DE60014915T patent/DE60014915T2/en not_active Expired - Fee Related
- 2000-08-09 WO PCT/US2000/021836 patent/WO2001011967A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP1202628A4 (en) | 2002-10-30 |
CA2379356A1 (en) | 2001-02-22 |
DE60014915T2 (en) | 2005-10-13 |
JP2003506467A (en) | 2003-02-18 |
EP1202628A1 (en) | 2002-05-08 |
EP1202628B1 (en) | 2004-10-13 |
DE60014915D1 (en) | 2004-11-18 |
WO2001011967A1 (en) | 2001-02-22 |
AU6629000A (en) | 2001-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200002480T2 (en) | Guanidine derivatives for the treatment of izazemi | |
DK1070056T3 (en) | Phthalazinone PDE III / IV Inhibitors | |
DK1200412T3 (en) | Antiproliferative imidazole compounds | |
TR200201505T2 (en) | Pirazolopyrimidines as therapeutic agents | |
PT1206467E (en) | N-HETEROCYCLIC DERIVATIVES AS US INHIBITORS | |
ATE302775T1 (en) | CARBOLINE DERIVATIVES | |
ATE389635T1 (en) | PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES | |
ATE301653T1 (en) | PYRAZOLOPYRIDINES | |
TR200302268T4 (en) | N-heterocyclic derivatives useful as NOS inhibitors. | |
ATE300541T1 (en) | PYRAZOLOPYRIDINE DERIVATIVES | |
ATE346067T1 (en) | CARBOLINE DERIVATIVES | |
GB0308201D0 (en) | Novel compounds | |
PE20030061A1 (en) | 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS | |
MXPA04006041A (en) | Pyridoquinoxaline antivirals. | |
AU2001263278A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
TR200201128T2 (en) | Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors. | |
PT1109560E (en) | USEFUL COMPOUNDS AS AICARFT INIDERS | |
NO20015892L (en) | Inhibitors of metal proteinases | |
AU2001296699A1 (en) | Condensed pyrazindione derivatives as pde inhibitors | |
DK1015437T3 (en) | Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals | |
DE60213798D1 (en) | Carbolic derivatives as PDEV inhibitors | |
PL359409A1 (en) | Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity | |
ATE279113T1 (en) | HYPOXANTHINE AND THIOHYPXANTHINE COMPOUNDS | |
SE9904128D0 (en) | Novel compounds | |
ATE246174T1 (en) | TOSYLPROLINE DERIVATIVES AS THYMIDYLATE SYNTHASE INHIBITORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |